338 related articles for article (PubMed ID: 25690088)
1. Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.
Ham AS; Buckheit RW
Ther Deliv; 2015 Feb; 6(2):217-29. PubMed ID: 25690088
[TBL] [Abstract][Full Text] [Related]
2. Permeation enhancer strategies in transdermal drug delivery.
Marwah H; Garg T; Goyal AK; Rath G
Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
[TBL] [Abstract][Full Text] [Related]
3. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
Ahmed TA; El-Say KM
Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in transdermal drug delivery.
Subedi RK; Oh SY; Chun MK; Choi HK
Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
[TBL] [Abstract][Full Text] [Related]
6. Topical and transdermal delivery of caffeine.
Luo L; Lane ME
Int J Pharm; 2015 Jul; 490(1-2):155-64. PubMed ID: 26004004
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of therapeutic agents using dendrimers (US20140018435A1): a patent evaluation.
Yang J; Hu J; He B; Cheng Y
Expert Opin Ther Pat; 2015; 25(10):1209-14. PubMed ID: 26150049
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of antidiabetic drugs: formulation and delivery strategies.
Ahad A; Al-Saleh AA; Akhtar N; Al-Mohizea AM; Al-Jenoobi FI
Drug Discov Today; 2015 Oct; 20(10):1217-27. PubMed ID: 26100737
[TBL] [Abstract][Full Text] [Related]
9. Designing and developing suppository formulations for anti-HIV drug delivery.
Ham AS; Buckheit RW
Ther Deliv; 2017 Aug; 8(9):805-817. PubMed ID: 28825395
[TBL] [Abstract][Full Text] [Related]
10. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
11. Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid.
Miwa Y; Hamamoto H; Ishida T
Eur J Pharm Biopharm; 2016 May; 102():92-100. PubMed ID: 26945484
[TBL] [Abstract][Full Text] [Related]
12. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
Patil UK; Saraogi R
Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
[TBL] [Abstract][Full Text] [Related]
13. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
[TBL] [Abstract][Full Text] [Related]
14. Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation.
Liu C; Fang L
AAPS PharmSciTech; 2015 Dec; 16(6):1245-53. PubMed ID: 25771739
[TBL] [Abstract][Full Text] [Related]
15. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
[TBL] [Abstract][Full Text] [Related]
16. Spray-on transdermal drug delivery systems.
Ibrahim SA
Expert Opin Drug Deliv; 2015 Feb; 12(2):195-205. PubMed ID: 25227233
[TBL] [Abstract][Full Text] [Related]
17. Recent advances on self modified patch for (trans) dermal drug delivery.
Pandey S; Patil A
Recent Pat Drug Deliv Formul; 2015; 9(1):88-94. PubMed ID: 24981287
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Soler LI; Boix A; Lauroba J; Colom H; Domenech J
Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation.
Chen Y; Quan P; Liu X; Guo W; Song W; Cun D; Wang Z; Fang L
J Pharm Pharmacol; 2015 Sep; 67(9):1232-9. PubMed ID: 25994482
[TBL] [Abstract][Full Text] [Related]
20. Maximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gels.
Zidan AS; Habib MJ
J Pharm Sci; 2014 Mar; 103(3):952-64. PubMed ID: 24464823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
